Crispr Therapeutics shares owned by Stifel Financial
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Stifel Financial
from 13F filings
Historical chart of Stifel Financial investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Stifel Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Stifel Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.5M | 39k | 64.81 |
| 2025-06-30 | $2.1M | 43k | 48.64 |
| 2025-03-31 | $1.3M | 39k | 34.03 |
| 2024-12-31 | $1.7M | 43k | 39.36 |
| 2024-09-30 | $1.9M | 40k | 46.98 |
| 2024-06-30 | $2.7M | 50k | 54.01 |
| 2024-03-31 | $4.1M | 59k | 68.16 |
| 2023-12-31 | $3.4M | 55k | 62.60 |
| 2023-09-30 | $1.2M | 27k | 45.39 |
| 2023-06-30 | $1.6M | 29k | 56.14 |
| 2023-03-31 | $1.3M | 30k | 45.23 |
| 2022-12-31 | $1.2M | 30k | 40.65 |
| 2022-09-30 | $1.9M | 29k | 65.36 |
| 2022-06-30 | $1.4M | 23k | 60.77 |
| 2022-03-31 | $2.1M | 34k | 62.78 |
| 2021-12-31 | $2.2M | 29k | 75.77 |
| 2021-09-30 | $4.0M | 35k | 111.93 |
| 2021-06-30 | $3.6M | 22k | 161.90 |
| 2021-03-31 | $2.7M | 23k | 121.84 |
| 2020-12-31 | $2.6M | 17k | 153.07 |
| 2020-09-30 | $1.1M | 13k | 83.67 |
| 2020-06-30 | $875k | 12k | 73.54 |
| 2020-03-31 | $523k | 12k | 42.57 |
| 2019-12-31 | $705k | 12k | 60.95 |
| 2019-09-30 | $400k | 9.8k | 40.84 |
| 2019-06-30 | $399k | 8.3k | 48.05 |